<p>Cross Country Healthcare（纳斯达克股票代码：CCRN - 获取免费报告）于周四发布了其财报。该商业服务提供商报告本季度每股收益为（$0.03），超出分析师一致预期的（$0.05）$0.02，FiscalAI 报道。该公司本季度的收入为 2.4106 亿美元，而分析师预期为 2.3684 亿美元。Cross Country Healthcare 的净利润率为-9.84%，股本回报率为-0.71%。</p>
<h2>Cross Country Healthcare 股票表现</h2>
<ul>
<li>在降息前值得购买的前两只小型医疗股</li>
</ul>
<p>周五午盘交易中，CCRN 上涨$0.09，达到$13.18。该公司的交易量为 1,809,683 股，而其平均交易量为 620,874 股。该公司的市值为 4.244 亿美金，市盈率为-4.32，市盈增长比率为 13.78，贝塔值为 0.35。Cross Country Healthcare 的 12 个月最低价为$7.43，最高价为$14.99。该公司的 50 日简单移动平均线为$9.69，200 日简单移动平均线为$9.66。</p>
<h2>更多 Cross Country Healthcare 新闻</h2>
<p>以下是本周影响 Cross Country Healthcare 的主要新闻：</p>
<ul>
<li>积极情绪：Cross Country Healthcare 同意被 Knox Lane 以全现金交易收购，给股东提供每股固定收购价$13.25，支持了该股票。Cross Country Healthcare 将被 Knox Lane 以价值 4.37 亿美元的全现金交易收购</li>
<li>积极情绪：该公司第一季度的业绩超出华尔街预期，损失小于预期的每股$0.03，收入为 2.4106 亿美元，这可能为情绪提供了一些支持。Cross Country Healthcare（CCRN）报告第一季度亏损，超出收入预期</li>
<li>中性情绪：Benchmark 重申对 CCRN 的 <strong>持有</strong> 评级，而 Wedbush 将该股票下调至 <strong>持有</strong> 并将其目标价下调至$13.25，反映出相对于交易价格的有限上行空间。Benchmark 重申持有评级</li>
<li>中性情绪：一些评论认为投资者可能希望在合并公告后兑现，但这主要是对收购消息的反应，而不是单独的运营发展。Cross Country Healthcare：在新合并后是时候兑现了</li>
</ul>
<h2>对 Cross Country Healthcare 的对冲基金看法</h2>
<ul>
<li>这家小型医疗公司表现优于其指数</li>
</ul>
<p>几家大型投资者最近对该公司的持仓进行了调整。Alliancebernstein L.P.在第二季度将其在 Cross Country Healthcare 的股份增加了 4.0%。Alliancebernstein L.P.现在拥有 2,438,282 股该商业服务提供商的股票，价值 3182 万美元，此前在该期间内增持了 94,798 股。高盛集团在第一季度将其在 Cross Country Healthcare 的股份增加了 56.9%。高盛集团现在拥有 1,095,178 股该商业服务提供商的股票，价值 1630.7 万美元，此前在该期间内增持了 397,216 股。Quinn Opportunity Partners LLC 在第四季度获得了 Cross Country Healthcare 的新头寸，价值 847 万美元。查尔斯·施瓦布投资管理公司在第四季度将其在 Cross Country Healthcare 的股份增加了 28.0%。查尔斯·施瓦布投资管理公司现在拥有 969,458 股该商业服务提供商的股票，价值 785.3 万美元，此前在该期间内增持了 211,925 股。最后，Geode Capital Management LLC 在第四季度将其在 Cross Country Healthcare 的股份增加了 1.7%。Geode Capital Management LLC 现在拥有 893,620 股该商业服务提供商的股票，价值 724 万美元，此前在该期间内增持了 14,733 股。机构投资者和对冲基金持有该公司 96.03% 的股份。</p>
<h2>分析师升级和降级</h2>
<p>几位股票研究分析师最近对该股票发布了报告。Wedbush 将 Cross Country Healthcare 的股票评级从 “跑赢大盘” 下调至 “持有”，并在周四的研究报告中将其目标价从$15.00 下调至$13.25。Cross Research 在 3 月 5 日的研究报告中对 Cross Country Healthcare 设定了$14.00 的目标价。花旗集团在周四的报告中将 Cross Country Healthcare 的评级从 “市场跑赢” 下调至 “市场表现”。Benchmark 在周五的报告中重新发布了对 Cross Country Healthcare 的 “持有” 评级。最后，Weiss Ratings 在 3 月 27 日的报告中重新发布了对 Cross Country Healthcare 的 “卖出（e+）” 评级。一位研究分析师对该股票给予了买入评级，七位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat，该公司目前的平均评级为 “持有”，共识目标价为$12.31。</p>
<p><strong>查看我们关于 Cross Country Healthcare 的最新研究报告</strong></p>
<h2>Cross Country Healthcare 公司简介</h2>
<p>（获取免费报告）</p>
<p>Cross Country Healthcare, Inc.总部位于佛罗里达州博卡拉顿，是美国领先的医疗劳动力解决方案提供商。该公司专注于护理和相关健康专业人员的招聘、安置和管理，包括旅行和永久性职位。通过其综合平台，Cross Country Healthcare 为医院、健康系统和长期护理设施提供服务，通过匹配合格的临床人才与不同护理环境中的患者护理需求。</p>
<p>公司的核心服务包括旅行护士和相关健康人员的招聘、临时人员招聘、永久安置服务和管理服务项目。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Cross Country Healthcare</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0NSTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0NSTg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Cross Country Healthcare 吗？</h2>
<p>在考虑 Cross Country Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Cross Country Healthcare 并不在名单上。</p>
<p>虽然 Cross Country Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Cross Country医疗保健

美国医疗保健供应商 ETF - iShares

医疗业 ETF - SPDR

标普全球医疗股指数 ETF - iShares

标普医疗保健服务 ETF - SPDR

医疗业 ETF - Vanguard

<p>Cross Country Healthcare（纳斯达克代码：CCRN）报告的季度每股收益为（$0.03），超出预期的（$0.05）$0.02。该公司实现收入 2.4106 亿美元，超过预期的 2.3684 亿美元。尽管净利润率为负的 9.84% 和股本回报率为-0.71%，但股价略微上涨至$13.18。该公司将被 Knox Lane 以每股$13.25 收购，这影响了市场情绪。分析师的评级不一，有些下调了该股票的评级，而其他则维持持有评级</p>

<p>Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) released its earnings results on Thursday. The business services provider reported ($0.03) earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02, FiscalAI reports. The firm had revenue of $241.06 million during the quarter, compared to analyst estimates of $236.84 million. Cross Country Healthcare had a negative net margin of 9.84% and a negative return on equity of 0.71%.</p>
<div class="lb-trans"><p>Cross Country Healthcare（纳斯达克股票代码：CCRN - 获取免费报告）于周四发布了其财报。该商业服务提供商报告本季度每股收益为（$0.03），超出分析师一致预期的（$0.05）$0.02，FiscalAI 报道。该公司本季度的收入为 2.4106 亿美元，而分析师预期为 2.3684 亿美元。Cross Country Healthcare 的净利润率为-9.84%，股本回报率为-0.71%。</p>
</div><h2>Cross Country Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>Cross Country Healthcare 股票表现</h2>
</div><ul>
<li>Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts</li>
</ul>
<div class="lb-trans"><ul>
<li>在降息前值得购买的前两只小型医疗股</li>
</ul>
</div><p>CCRN traded up $0.09 during midday trading on Friday, hitting $13.18. The company had a trading volume of 1,809,683 shares, compared to its average volume of 620,874. The company has a market capitalization of $424.40 million, a PE ratio of -4.32, a P/E/G ratio of 13.78 and a beta of 0.35. Cross Country Healthcare has a twelve month low of $7.43 and a twelve month high of $14.99. The firm's 50-day simple moving average is $9.69 and its 200-day simple moving average is $9.66.</p>
<div class="lb-trans"><p>周五午盘交易中，CCRN 上涨$0.09，达到$13.18。该公司的交易量为 1,809,683 股，而其平均交易量为 620,874 股。该公司的市值为 4.244 亿美金，市盈率为-4.32，市盈增长比率为 13.78，贝塔值为 0.35。Cross Country Healthcare 的 12 个月最低价为$7.43，最高价为$14.99。该公司的 50 日简单移动平均线为$9.69，200 日简单移动平均线为$9.66。</p>
</div><h2>More Cross Country Healthcare News</h2>
<div class="lb-trans"><h2>更多 Cross Country Healthcare 新闻</h2>
</div><p>Here are the key news stories impacting Cross Country Healthcare this week:</p>
<div class="lb-trans"><p>以下是本周影响 Cross Country Healthcare 的主要新闻：</p>
</div><ul>
<li>Positive Sentiment: Cross Country Healthcare agreed to be acquired by Knox Lane in an all-cash transaction, giving shareholders a fixed buyout price of $13.25 per share and supporting the stock. Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million</li>
<li>Positive Sentiment: The company’s Q1 results beat Wall Street expectations, with a smaller-than-expected loss of $0.03 per share and revenue of $241.06 million, which may have added some support to sentiment. Cross Country Healthcare (CCRN) Reports Q1 Loss, Beats Revenue Estimates</li>
<li>Neutral Sentiment: Benchmark reaffirmed its <strong>hold</strong> rating on CCRN, while Wedbush downgraded the stock to <strong>hold</strong> and trimmed its price target to $13.25, reflecting limited upside versus the deal price. Benchmark Reaffirms Hold Rating</li>
<li>Neutral Sentiment: Some commentary suggested investors may want to cash out after the merger announcement, but this is largely a reaction to the acquisition news rather than a separate operating development. Cross Country Healthcare: Time To Cash Out After A New Merger</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：Cross Country Healthcare 同意被 Knox Lane 以全现金交易收购，给股东提供每股固定收购价$13.25，支持了该股票。Cross Country Healthcare 将被 Knox Lane 以价值 4.37 亿美元的全现金交易收购</li>
<li>积极情绪：该公司第一季度的业绩超出华尔街预期，损失小于预期的每股$0.03，收入为 2.4106 亿美元，这可能为情绪提供了一些支持。Cross Country Healthcare（CCRN）报告第一季度亏损，超出收入预期</li>
<li>中性情绪：Benchmark 重申对 CCRN 的 <strong>持有</strong> 评级，而 Wedbush 将该股票下调至 <strong>持有</strong> 并将其目标价下调至$13.25，反映出相对于交易价格的有限上行空间。Benchmark 重申持有评级</li>
<li>中性情绪：一些评论认为投资者可能希望在合并公告后兑现，但这主要是对收购消息的反应，而不是单独的运营发展。Cross Country Healthcare：在新合并后是时候兑现了</li>
</ul>
</div><h2>Hedge Funds Weigh In On Cross Country Healthcare</h2>
<div class="lb-trans"><h2>对 Cross Country Healthcare 的对冲基金看法</h2>
</div><ul>
<li>This Small-Cap Healthcare Name Is Outperforming Its Index</li>
</ul>
<div class="lb-trans"><ul>
<li>这家小型医疗公司表现优于其指数</li>
</ul>
</div><p>Several large investors have recently made changes to their positions in the company. Alliancebernstein L.P. lifted its stake in shares of Cross Country Healthcare by 4.0% during the second quarter. Alliancebernstein L.P. now owns 2,438,282 shares of the business services provider's stock valued at $31,820,000 after acquiring an additional 94,798 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Cross Country Healthcare by 56.9% during the first quarter. Goldman Sachs Group Inc. now owns 1,095,178 shares of the business services provider's stock valued at $16,307,000 after acquiring an additional 397,216 shares during the period. Quinn Opportunity Partners LLC acquired a new position in shares of Cross Country Healthcare during the fourth quarter valued at $8,470,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Cross Country Healthcare by 28.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 969,458 shares of the business services provider's stock valued at $7,853,000 after acquiring an additional 211,925 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of Cross Country Healthcare by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 893,620 shares of the business services provider's stock valued at $7,240,000 after acquiring an additional 14,733 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.</p>
<div class="lb-trans"><p>几家大型投资者最近对该公司的持仓进行了调整。Alliancebernstein L.P.在第二季度将其在 Cross Country Healthcare 的股份增加了 4.0%。Alliancebernstein L.P.现在拥有 2,438,282 股该商业服务提供商的股票，价值 3182 万美元，此前在该期间内增持了 94,798 股。高盛集团在第一季度将其在 Cross Country Healthcare 的股份增加了 56.9%。高盛集团现在拥有 1,095,178 股该商业服务提供商的股票，价值 1630.7 万美元，此前在该期间内增持了 397,216 股。Quinn Opportunity Partners LLC 在第四季度获得了 Cross Country Healthcare 的新头寸，价值 847 万美元。查尔斯·施瓦布投资管理公司在第四季度将其在 Cross Country Healthcare 的股份增加了 28.0%。查尔斯·施瓦布投资管理公司现在拥有 969,458 股该商业服务提供商的股票，价值 785.3 万美元，此前在该期间内增持了 211,925 股。最后，Geode Capital Management LLC 在第四季度将其在 Cross Country Healthcare 的股份增加了 1.7%。Geode Capital Management LLC 现在拥有 893,620 股该商业服务提供商的股票，价值 724 万美元，此前在该期间内增持了 14,733 股。机构投资者和对冲基金持有该公司 96.03% 的股份。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>Several equities research analysts have recently issued reports on the stock. Wedbush downgraded shares of Cross Country Healthcare from an &#34;outperform&#34; rating to a &#34;hold&#34; rating and lowered their price objective for the stock from $15.00 to $13.25 in a research note on Thursday. Cross Research set a $14.00 price objective on Cross Country Healthcare in a research note on Thursday, March 5th. Citigroup downgraded Cross Country Healthcare from a &#34;market outperform&#34; rating to a &#34;market perform&#34; rating in a report on Thursday. Benchmark reissued a &#34;hold&#34; rating on shares of Cross Country Healthcare in a report on Friday. Finally, Weiss Ratings reissued a &#34;sell (e+)&#34; rating on shares of Cross Country Healthcare in a report on Friday, March 27th. One research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of &#34;Hold&#34; and a consensus target price of $12.31.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对该股票发布了报告。Wedbush 将 Cross Country Healthcare 的股票评级从 “跑赢大盘” 下调至 “持有”，并在周四的研究报告中将其目标价从$15.00 下调至$13.25。Cross Research 在 3 月 5 日的研究报告中对 Cross Country Healthcare 设定了$14.00 的目标价。花旗集团在周四的报告中将 Cross Country Healthcare 的评级从 “市场跑赢” 下调至 “市场表现”。Benchmark 在周五的报告中重新发布了对 Cross Country Healthcare 的 “持有” 评级。最后，Weiss Ratings 在 3 月 27 日的报告中重新发布了对 Cross Country Healthcare 的 “卖出（e+）” 评级。一位研究分析师对该股票给予了买入评级，七位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat，该公司目前的平均评级为 “持有”，共识目标价为$12.31。</p>
</div><p><strong>View Our Latest Research Report on Cross Country Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Cross Country Healthcare 的最新研究报告</strong></p>
</div><h2>Cross Country Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Cross Country Healthcare 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.</p>
<div class="lb-trans"><p>Cross Country Healthcare, Inc.总部位于佛罗里达州博卡拉顿，是美国领先的医疗劳动力解决方案提供商。该公司专注于护理和相关健康专业人员的招聘、安置和管理，包括旅行和永久性职位。通过其综合平台，Cross Country Healthcare 为医院、健康系统和长期护理设施提供服务，通过匹配合格的临床人才与不同护理环境中的患者护理需求。</p>
</div><p>The company's core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.</p>
<div class="lb-trans"><p>公司的核心服务包括旅行护士和相关健康人员的招聘、临时人员招聘、永久安置服务和管理服务项目。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Cross Country Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Cross Country Healthcare</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0NSTg" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=CCRN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cross Country Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Cross Country Healthcare 吗？</h2>
</div><p>Before you consider Cross Country Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cross Country Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Cross Country Healthcare 并不在名单上。</p>
</div><p>While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cross Country Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cross Country Healthcare (NASDAQ:CCRN) Releases Earnings Results, Beats Expectations By $0.02 EPS

Market Beat

AllianceBernstein

高盛

嘉信理财

Dan IVES Wedbush AI Revolution ETF

花旗

GS Hldg R

SCHWAB(CHARLES)CORP 5.95% DEP SHS REP 1/40 NON CUM PERP PF D

SCHWAB(CHARLES)CORP 4.450% DEP SHS REP 1/40TH N-CUM PFD SERJ

CITIGROUP INC 6.250 NON CUM SER II PFD WI

Cross Country Healthcare（纳斯达克代码：CCRN）公布财报，超出预期每股收益 0.02 美元